Skip to content

    Lucid Diagnostics (LUCD) stock price & financials

    View LUCD earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance21.4% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $1.17M
    $1.20M
    $828.0K
    $1.16M
    $1.21M
    +3.3%
    $1.50M
    +25.6%
    $1.26M
    +51.7%
    $1.47M
    +26.7%
    Strengthening
    Operating Profit
    -$11.69M
    -$12.37M
    -$12.49M
    -$11.38M
    -$11.76M
    -0.6%
    -$14.01M
    -13.2%
    -$12.11M
    +3.0%
    -$12.80M
    -12.4%
    Weakening
    Net Profit
    -$12.37M
    -$11.54M
    -$26.91M
    -$4.44M
    -$10.40M
    +16.0%
    -$16.27M
    -40.9%
    -$13.91M
    +48.3%
    -$11.69M
    -163.3%
    Weakening
    EPS
    $-0.25
    $-0.52
    $-0.08
    $-0.10
    +60.0%
    $-0.17
    +67.3%
    $-0.08
    +0.0%
    Strengthening
    Other Income
    -$14.42M
    $6.95M
    -$1.79M
    +87.6%
    $1.11M
    -84.0%
    Stable
    Interest
    $1.0K
    $7.0K
    $9.0K
    $6.0K
    $2.0K
    +100.0%
    $5.0K
    -28.6%
    $6.0K
    -33.3%
    $4.0K
    -33.3%
    Weakening
    Depreciation
    Profit before Tax
    -$12.37M
    -$11.54M
    -$26.91M
    -$4.44M
    -$10.40M
    +16.0%
    -$16.27M
    -40.9%
    -$13.91M
    +48.3%
    -$11.69M
    -163.3%
    Weakening
    MarginsOPM
    -997.8%
    -1033.8%
    -1508.1%
    -978.9%
    -971.0%
    +2.7%
    -931.5%
    +9.9%
    -964.5%
    +36.0%
    -868.5%
    +11.3%
    Strengthening
    Tax
    0.0%
    0.0%
    0.0%
    0.0%
    ReturnsROIC
    4.0%
    3.7%
    8.6%
    1.4%
    3.3%
    -16.0%
    5.2%
    +40.9%
    4.5%
    -48.3%
    3.7%
    +163.3%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$53.66M$22.47M$18.90M$22.36M
    Short-Term Investments
    Total Current Assets$1.44M$57.30M$24.36M$22.07M$25.15M$37.47M$36.62M
    Net PP&E$971.0K$3.60M$2.64M$3.70M$2.62M$2.21M
    Goodwill
    Intangibles$3.44M$1.42M$736.0K$315.0K$105.0K
    Total Assets$2.19M$59.00M$32.51M$27.27M$30.71M$40.45M$38.95M
    LiabilitiesTotal Current Liabilities$4.26M$8.43M$29.38M$23.52M$28.58M$27.52M
    Short-Term Debt
    Long-Term Debt$13.26M
    Long-Term Leases$1.04M$199.0K$1.80M$927.0K$503.0K
    Total Liabilities$15.71M$4.26M$9.46M$29.58M$25.32M$29.51M$28.02M
    EquityCommon Stock & APIC$14.0K$35.0K$41.0K$42.0K$63.0K$131.0K$191.0K
    Retained Earnings-$13.83M-$41.90M-$98.08M-$150.74M-$203.77M-$274.33M-$312.68M
    Total Equity-$13.52M$54.74M$23.05M-$2.31M$5.39M$10.94M$10.93M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$5.63M-$17.67M-$29.68M-$32.82M-$44.14M-$46.48M-$46.87M
    Cash from Investing-$862.0K-$4.11M-$221.0K-$646.0K-$197.0K-$315.0K
    Cash from Financing$5.58M$72.08M$2.61M$29.46M$48.25M$59.03M$49.47M
    SummaryCapital Expenditure-$862.0K-$3.20M-$296.0K-$197.0K
    Free Cash Flow-$18.53M-$32.88M-$44.44M-$46.68M
    FCF Margin-3706.0%-8722.8%-1022.5%-992.0%

    Ratios